| Ytd | 11.12% | |
| 1y | -10.32% |
| Open | 30.36 | Prev Close | 30.92 | Low | 29.69 | High | 30.99 | Mkt Cap | 8.47B |
| Vol | 14.72M | Avg Vol | 4.75M | EPS | 9.58 | P/E | 3.13 | Forward P/E | 79.82 |
| Beta | 1.10 | Short Ratio | 2.39 | Inst. Own | 56.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 21.56 | 200-d Avg | 21.04 | 1yr Est | 27.54 |
Caris Life Sciences has an already established profiling business that provides revenue and cash flo
Caris Life Sciences, Inc. (CAI) was a big mover last session on higher-than-average trading volume.
The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p
The study demonstrates the performance of Caris AI Insights™ to predict first-line treatment benefit
Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. E